An increased percentage of myeloid CD34+ bone marrow cells stratifies intermediate IPSS ‐R myelodysplastic syndrome patients into prognostically significant groups

International Journal of Laboratory Hematology, EarlyView.

Source: Clinical and Laboratory Haematology - May 18, 2018 Category: Hematology Authors: T. ‐H. Chen‐Liang , A. M. Casado‐Prieto , V. Campos‐Rodríguez , A. M. Hurtado , M. L. Amigo , M. D. García‐Malo , V. Vicente , F. J. Ortuño , A. Jerez Source Type: research